<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01986257</url>
  </required_header>
  <id_info>
    <org_study_id>DNR 2013/1321-31/3</org_study_id>
    <nct_id>NCT01986257</nct_id>
  </id_info>
  <brief_title>ERGT for Women Engaging in NSSI - an Effectiveness Study</brief_title>
  <official_title>Emotion Regulation Group Therapy (ERGT) for Women Engaging in Non-suicidal Self-Injury (NSSI) - an Effectiveness Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim is to investigate the effectiveness of Emotion Regulation Group Therapy
      (ERGT) for women who self-harm in ordinary psychiatric outpatient health care.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of non-suicidal self-injury as measured by Deliberate Self-Harm Inventory (DSHI)</measure>
    <time_frame>Baseline (from inclusion to treatment start), (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks) and six and twelve months follow-up.</time_frame>
    <description>Change from Baseline in deliberate self-harm after 14 weeks and at 6- and 12 months after treatment has ended.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Borderline Symptom List Behavior supplement (BSL-supplement)</measure>
    <time_frame>Baseline (from inclusion to treatment start), pre-treatment (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks), and six and twelve months follow-up.</time_frame>
    <description>Change from Baseline in self-destructive behaviors after 14 weeks and at 6- and 12 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficulties in Emotion Regulation Scale (DERS)</measure>
    <time_frame>Baseline (from inclusion to treatment start), pre-treatment (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks) and six and twelve months follow-up.</time_frame>
    <description>Change from Baseline in difficulties with emotion regulation after 14 weeks and at 6- and 12 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diary questionnaire (DQ)</measure>
    <time_frame>Baseline (from inclusion to treatment start), pre-treatment (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks) and six and twelve months follow-up.</time_frame>
    <description>Change from Baseline in positive and negative affect after 14 weeks and at 6- and 12 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Borderline Evaluation of Severity over Time (BEST).</measure>
    <time_frame>Pre-treatment (7 days prior to treatment start), post-treatment (14 weeks) and six and twelve months follow-up.</time_frame>
    <description>Change from Baseline in Borderline severity symptoms after 14 weeks and at 6- and 12 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Depression Anxiety Stress Scales (DASS)</measure>
    <time_frame>Pre-treatment (7 days prior to treatment start), post-treatment (14 weeks) and six and twelve months follow-up.</time_frame>
    <description>Change from Baseline in depression and anxiety after 14 weeks and at 6- and 12 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inventory of Interpersonal Problems - Borderline Personality Disorder (IIP-BPD)</measure>
    <time_frame>Pre-treatment (7 days prior to treatment start), post-treatment (14 weeks) and six and twelve months follow-up.</time_frame>
    <description>Change from Baseline in interpersonal problems after 14 weeks and at 6- and 12 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sheehan Disability Scale (SDS)</measure>
    <time_frame>Pre-treatment (7 days prior to treatment start), post-treatment (14 weeks) and six and twelve months follow-up.</time_frame>
    <description>Change from Baseline in global functioning after 14 weeks and at 6- and 12 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trimbos and Institute of Technology Cost Questionnaire for Psychiatry (TIC-P)</measure>
    <time_frame>Baseline, post-treatment (14 weeks) and six and twelve months follow-up.</time_frame>
    <description>Change from Baseline in societal costs after 14 weeks and at 6- and 12 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Euroqol-5D (EQ-5D)</measure>
    <time_frame>Baseline, post-treatment (14 weeks) and six and twelve months follow-up.</time_frame>
    <description>Change from Baseline in quality of life after 14 weeks and at 6- and 12 months after treatment has ended.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">97</enrollment>
  <condition>Borderline Personality Disorder</condition>
  <condition>Non-suicidal Self-injury (NSSI)</condition>
  <arm_group>
    <arm_group_label>Emotion Regulation Group Therapy (ERGT).</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Emotion Regulation Group Therapy (ERGT).</intervention_name>
    <arm_group_label>Emotion Regulation Group Therapy (ERGT).</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  NSSI a minimum of three times in the last six months

          -  Meets at least three criteria for Borderline Personality Disorder according to
             DSM-IV-TR

          -  Contact with an other individual therapist, psychiatrist, &quot;case manager&quot; or equal

        Exclusion Criteria:

          -  Insertion/withdrawal of psychopharmacological substances within two months prior to
             the treatment

          -  Other acute primary axis I diagnosis (e.g. anorexia nervosa) that demand treatment in
             first hand

          -  Bipolar disorder I or primary psychosis

          -  Current substance dependence (the last month)

          -  Current life circumstances that would hinder the treatment (i.e. ongoing domestic
             abuse)

          -  Insufficient Swedish language skills

          -  Cocurrent treatment with Mentalization based therapy (MBT) or Dialectical behavioral
             therapy (DBT)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre for Psychiatry Research Karolinska Institutet and Stockholm County Council</name>
      <address>
        <city>Stockholm</city>
        <zip>113 64</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2013</study_first_submitted>
  <study_first_submitted_qc>November 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2013</study_first_posted>
  <last_update_submitted>November 2, 2017</last_update_submitted>
  <last_update_submitted_qc>November 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Clara Hellner Gumpert</investigator_full_name>
    <investigator_title>Ph.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Personality Disorders</mesh_term>
    <mesh_term>Borderline Personality Disorder</mesh_term>
    <mesh_term>Self-Injurious Behavior</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

